← SynDRA

ORITAVANCIN

SynDRA canonical compound SYN0026427 — structure-anchored drug synonym record

All known targets

• Bact folP

Mechanisms of action (all sources)

• bacterial cell wall synthesis inhibitor
• Inhibitor

Drug classes

• Anti-Bacterial Agents
• Anti-Infective Agents
• Cytochrome P450 2C19 Inhibitors
• Cytochrome P450 2C9 Inhibitors
• Cytochrome P450 3A4 Inducers
• Cytochrome P450 2D6 Inducers
• Lipoglycopeptide Antibacterial

ATC classes

• J01X · OTHER ANTIBACTERIALS

Cross-references

• PubChem CID: 16136912
• ChEMBL: CHEMBL1688530
• DrugBank: DB04911
• ChEBI: CHEBI:83305
• KEGG: D05271
• RxNorm: 1547611
• Wikipedia: Oritavancin
• TTD: D02IBU

Synonyms

• oritavancin diphosphate
• orbactiv
• LY333328
• Oritavancine
• Oritavancina
• LY-333328
• Nuvocid
• Oritavancin [INN]
• Chlorobiphenyl-chloroeremomycin
• (3S,6R,7R,22R,23S,26S,36R,38aR)-22-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-mannopyranosyloxy)-3-(carbamoylmethyl)-10,19-dichloro-44-[2-O-[3-(4'-chlorobiphenyl-4-ylmethylamino)-2,3,6-trideoxy-3-C-me
• (4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N3''-(4'-chloro[1,1'-biphenyl]-4-ylmethyl)vancomycin
• (4''R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabinohexopyranosyl)-N3''-(p-(p-chlorophenyl)benzyl)vancomycin
• LY 333328
• PUG62FRZ2E
• oritavancina
• oritavancine
• CHEBI:82699
• oritavancinum
• oritavacin diphosphate
• RefChem:57173
• J01XA05
• DTXCID701326917
• UNII-PUG62FRZ2E
• Orita-vancin
• C12034
• ORITAVANCIN [MI]
• ORITAVANCIN [VANDF]
• ORITAVANCIN [MART.]
• ORITAVANCIN [WHO-DD]
• Oritavancin(LY-333328)
• Oritavancin; LY-333328
• orb1692501
• SCHEMBL9947049
• SCHEMBL29416865
• GTPL10877
• VHFGEBVPHAGQPI-LXKZPTCJSA-N
• BDBM513037
• GLXC-10720

Reported adverse events

• Dizziness
• Hypersensitivity
• Nausea
• Vomiting
• Abscess
• Alanine aminotransferase increased
• Aspartate aminotransferase increased
• Headache
• Osteomyelitis
• Tachycardia
• Infusion site phlebitis
• Infusion site reaction